Benitec Biopharma Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Benitec Biopharma Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2024.
  • Benitec Biopharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $21.7M, a 22.4% decline year-over-year.
  • Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $68M, a 325% increase from 2023.
  • Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $16M.
  • Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $22.5M, a 1172% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $68M +$52M +325% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-26
2023 $16M Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2021 $22.5M +$20.8M +1172% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-02
2020 $1.77M Jul 1, 2019 Jun 30, 2020 10-K 2021-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.